Oral anticoagulation after atrial fibrillation catheter ablation: benefits and risks
AbstractBackground and Aims. Few recent large-scale studies have evaluated the risks and benefits of continuing oral anticoagulant (OAC) therapy after catheter
AbstractBackground and Aims. Few recent large-scale studies have evaluated the risks and benefits of continuing oral anticoagulant (OAC) therapy after catheter
May 2, 2024 — Reprieve Cardiovascular, Inc. (‘Reprieve’), a development stage company focused on pioneering an intelligent approach to acute decompensated heart failure (ADHF) treatment, today highlighted…
May 2, 2024 — BioCardia, Inc., a developer of cellular and cell-derived therapeutics for the treatment of cardiovascular and pulmonary diseases, today announced the primary…
May 2, 2024 — Artificial intelligence experts at Cedars-Sinai and the Smidt Heart Institute created a dataset with more than 1 million echocardiograms, or cardiac…
Correspondence to: Rishi K. Wadhera, MD, MPP, MPhil, Section of Health Policy and Equity at the Richard A. and Susan F. Smith Center for Outcomes…
The study published in Neurology Clinical Practice states that people who take acid-reducing drugs may have a higher risk of migraine and other severe headache…
Developed by doctors, MedShr is the easiest & safest way for medical professionals to discover, discuss and share clinical cases and medical images. Join our…
4 hours of interactive, online, self-paced nutrition CME/CEU for busy clinicians.
People prepare smoked fish in Egypt before Sham el-Nessim-
The metabolic syndrome is a constellation of epidemics, involving type 2 diabetes mellitus (T2DM), hypertension, hyperlipidemia, and obesity, that share common biological and societal pathways.[1–4]…
AbstractAims. Deep learning methods have recently gained success in detecting left ventricular systolic dysfunction (LVSD) from electrocardiogram waveforms